Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1767687

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1767687

Eye Health Supplements Market, By Ingredients Type, By Indication Type, By Dosage Type, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 223 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Eye Health Supplements Market is estimated to be valued at USD 3,257.1 Mn in 2025 and is expected to reach USD 5,474.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,257.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.70% 2032 Value Projection: USD 5,474.5 Mn

Eye health is a growing concern owing to increased screen time and digital exposure. Common eye problems include eye strain, dry and red eyes, eye irritation, and watery eyes. Moreover, common eye diseases include Age-related Macular Degeneration (AMD), cataract, and glaucoma. Age-related macular degeneration is an eye disease that gets severe over time. The disease does not cause blindness but can cause severe vision-related problems. Some of the major symptoms of eye problems are less clear vision and worse colour perception.

Cataract occurs when the natural lens of eyes become cloudy. Proteins present in the eyes break down and this causes things to look blurry, hazy, or less colourful. Some of the major symptoms of cataract are blurry vision, seeing double objects, and having trouble seeing at night. Glaucoma is an eye disease that damages eye's optic nerve. Glaucoma is related to the build up of pressure inside the eyes. The increased pressure can cause damage to the optic nerve. If the damage is severe glaucoma can cause permanent vision loss. Some of the major symptoms of glaucoma are redness in eyes, eye pain, and seeing halos around light. Doctors prescribe medicines for eye related diseases, such as cataract, glaucoma, and others, which include ingredients such as lutein and zeaxanthin, omega-3 fatty acids, vitamin A, beta-carotene, and bilberry extracts.

Market Dynamics

Approval of new products by regulatory bodies is expected to propel the global eye health supplement market growth during the forecast period. For instance, on March 7, 2023, NovaBay Pharmaceuticals, Inc, a biopharmaceutical company that develops products for the eye care market, launched Avenova Eye Health Support, a new antioxidant-rich oral supplement to comfort dry eyes and promote the overall eye health.

Key features of the study:

  • This report provides an in-depth analysis of the global eye health supplements market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%) for the forecast period: 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global eye health supplement market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • The key players covered as a part of this study include: Pfizer, Inc., Bausch Health Companies Inc., Alcon Laboratories, Inc., Alliance Pharma PLC, Allied Biotech Corporation, BASF SE, Amway Corp., Butterflies Healthcare Ltd, Herballife Nutrition Ltd., SUSS Technology Corp., Eyescience Labs, Nordic Naturals, Vitabiotics Ltd., and Akorn Incorporated
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global eye health supplement market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for the global eye health supplements market, research and consulting firms, new entrants, and financial analysts

Market Segmentation:

  • Global Eye Health Supplements Market, By Ingredients Type:
    • Lutein And Zexanthin
    • Omega- 3 Fatty Acids
    • Vitamin A
    • Beta Carotene
    • Bilberry Extracts
    • Others
  • Global Eye Health Supplements Market, By Indication Type:
    • Age-related Macular Degeneration (AMD)
    • Cataract
    • Dry Eye Syndrome
    • Glaucoma
    • Others
  • Global Eye Health Supplements Market, By Dosage Type:
    • Tablets
    • Capsules
    • Soft Gels
    • Others
  • Global Eye Health Supplements Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Eye Health Supplements Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc
    • Bausch Health Companies Inc
    • Alcon
    • Alliance Pharma PLC
    • Allied Biotech Corporation
    • BASF SE
    • Amway India Enterprises Pvt. Ltd
    • Butterflies Healthcare Ltd
    • Herbalife International, Inc
    • Nordic Naturals
    • Vitabiotics Ltd
    • Akorn Operating Company LLC.
Product Code: CMI3791

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Ingredients Type
    • Market Snapshot, By Indication Type
    • Market Snapshot, By Dosage Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Eye Health Supplements Market, By Ingredients Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Lutein and Zeaxanthin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Omega-3 Fatty Acids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Vitamin A
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Beta - Carotene
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Bilberry Extracts
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

5. Global Eye Health Supplements Market, By Indication Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Age-related Macular Degeneration (AMD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Cataract
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Dry Eye Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Glaucoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Eye Health Supplements Market, By Dosage Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Soft Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Eye Health Supplements Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

8. Global Eye Health Supplements Market, By Region, 2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bausch Health Companies Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alcon
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alliance Pharma PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Allied Biotech Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amway India Enterprises Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Butterflies Healthcare Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Herbalife International, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nordic Naturals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vitabiotics Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Akorn Operating Company LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!